TOXEMIA OF PREGNANCY. II. IMMUNOFLUORESCENT STUDIES WITH PLACENTAL CONNECTIVE TISSUE ANTISERA: THE POSSIBILITY OF CHARACTERISTIC LESIONS.VARDI J.1976; OBSTETR. AND GYNECOL.; U.S.A.; DA. 1976; VOL. 48; NO 4; PP. 447-451; BIBL. 17 REF.Article

MICROANGIOPATHIC HEMOLYTIC ANEMIA IN SEVERE PRE-ECLAMPSIA. A REVIEW OF THE LITERATURE AND PATHOPHYSIOLOGYVARDI J; FIELDS GA.1974; AMER. J. OBSTETR. GYNECOL.; U.S.A.; DA. 1974; VOL. 119; NO 5; PP. 617-622; BIBL. 19REF.Article

Mediterranean - Dead sea canal project : Review of proposals = Projet de canal Mer Méditerranée, Mer Morte : Synthèse des propositionsVARDI, J.Israel geological Society, annual meeting. 1990, issn 0334-0694, 82Conference Paper

ON THE SYNCHRONIZING EFFECT OF AMATADINE-1-HYDROCHLORID (SYMMETREL) ON PATHOLOGICAL EEG-ACTIVITY.VARDI J; STREIFLER M.1975; J. NEUR. TRANSM.; AUSTR.; DA. 1975; VOL. 37; NO 1; PP. 73-80; BIBL. 16 REF.Article

Variable load pricing in the face of loss of load probabilityVARDI J; ZAHAVI J; AVI-ITZHAK B et al.The Bell Journal of Economics. 1977, Num 1, pp 270-288Article

TIME-DEPENDENT MARGINAL ENERGY COSTS IN POWER SYSTEMS WITH FORCED OUTAGESZAHAVI J; VARDI J; AVI ITZHAK B et al.1980; J. OPERAT. RES. SOC.; GBR; DA. 1980; VOL. 31; NO 6; PP. 507-516; BIBL. 7 REF.Article

TRAITEMENT PROLONGE DU PARKINSONISME PAR LA L-DOPA ET UN INHIBITEUR DES AMINOACIDES L-AROMATIQUESSTREIFLER M; VARDI J; KESTEN M et al.1972; HAREFUAH; ISRAEL; DA. 1972; VOL. 83; NO 9; PP. 362-364; ABS. ANGL.; BIBL. 17REF.Serial Issue

EEG SLEEP PATTERNS IN PARKINSONIAN PATIENTS TREATED WITH BROMOCRYPTINE AND L-DOPA: A COMPARATIVE STUDYVARDI J; GLAUBMAN H; RABEY J et al.1979; J. NEUR. TRANSM.; AUT; DA. 1979; VOL. 45; NO 4; PP. 307-316; BIBL. 4 P.Article

Peroxide formation in low sulfur automotive diesel fuelsVARDI, J; KRAUS, B. J.SAE transactions. 1992, Vol 101, Num 4, pp 916-929, issn 0096-736XArticle

PROSTAGLANDIN - E₂ LEVELS IN THE SALIVA OF COMMON MIGRAINOUS WOMENVARDI J; FLECHTER S; ALGUATI A et al.1983; HEADACHE; ISSN 0017-8748; USA; DA. 1983; VOL. 23; NO 2; PP. 59-61; BIBL. 20 REF.Article

ORGANIC DEPRESSIONVARDI J; CZERNIACK P; REGEV I et al.1979; ISRAEL ANN. PSYCHIATRY RELAT. DISCIPL.; ISR; DA. 1979; VOL. 17; NO 2; PP. 110-121; BIBL. 14 REF.Article

MYOCLONIC ATTACKS INDUCED BY L-DOPA AND BROMOCRYPTIN IN PARKINSON PATIENTS.VARDI J; GLAUBMAN H; RABEY JM et al.1978; J. NEUROL.; GERM.; DA. 1978; VOL. 218; NO 1; PP. 35-42; BIBL. 1 P. 1/2Article

THE MODULATORY EFFECT OF APIATE RECEPTOR INHIBITOR IN PARKINSONISMVARDI J; FLECHTER S; REGEV I et al.1979; CURR. THERAPEUT. RES.; USA; DA. 1979; VOL. 26; NO 6; SECT. 2; PP. 1015-1018; BIBL. 10 REF.Article

R.I.S.A. IN ORGANIC DEPRESSION.VARDI J; RABEY JM; SHAPIRA T et al.1978; ISRAEL ANN. PSYCHIATRY RELAT. DISCIPL.; ISR; DA. 1978; VOL. 16; NO 1; PP. 50-63; BIBL. 2 P.Article

APPLICATION OF CATALYSTS TO AUTOMOTIVE NOX EMISSIONS CONTROLBERNSTEIN LS; KEARBY KK; RAMAN AKS et al.1971; S.A.E. TRANS.; U.S.A.; DA. 1971; VOL. 80; NO PART. 1; PP. 42-62; BIBL. 10 REF.Serial Issue

CSF RENIN ACTIVITY IN HYPERTENSIVE AND NORMOTENSIVE PATIENTSVARDI J; KISCH E; BORNSTEIN N et al.1981; SCHWEIZ. ARCH. NEUROL. NEUROCHIR. PSYCHIATR.; ISSN 0036-7273; CHE; DA. 1981; VOL. 129; NO 2; PP. 347-352; ABS. FRE; BIBL. 19 REF.Article

PLASMA DOPAMINE BETA -HYDROXYLASE ACTIVITY IN CHRONIC SCHIZOPHRENIC PATIENTS TESTED WITH SINGLE DOSE OF 2-BROMO-ALPHA ERGOCRIPTINE (PARLODEL)VARDI J; FLECHTER S; OBERMAN Z et al.1981; ENCEPHALE; ISSN 0013-7006; FRA; DA. 1981; VOL. 7; NO 1; PP. 95-103; ABS. ENG; BIBL. 33 REF.Article

L-DOPA EFFECT ON PROLACTIN PLASMA LEVELS IN COMPLICATED AND COMMUN MIGRAINOUS PATIENTSVARDI J; FLECHTER S; AYALON D et al.1981; HEADACHE; ISSN 0017-8748; USA; DA. 1981; VOL. 21; NO 1; PP. 14-20; BIBL. 38 REF.Article

BETA-TYPE MONO-AMINE OXYDASE (M.A.O.) INHIBITORS IN LONG-TERM LEVO-DOPA-TREATED PARKINSONISM: A COMBINED CLINICAL TRIAL WITH L-DEPRENYLSTREIFLER M; VARDI J; BORENSTEIN N et al.1980; CURR. THERAPEUT. RES.; USA; DA. 1980; VOL. 27; NO 4; PP. 643-648; BIBL. 23 REF.Article

L-TRYPTOPHAN ADMINISTRATION IN L-DOPA-INDUCED HALLUCINATIONS IN ELDERLY PARKINSONIAN PATIENTS.RABEY JM; VARDI J; ASKENAZI JJ et al.1977; GERONTOLOGY; SUISSE; DA. 1977; VOL. 23; NO 6; PP. 438-444; BIBL. 27 REF.Article

MEASUREMENT OF PROSTAGLANDIN E2 IN CEREBROSPINAL FLUID IN PATIENTS SUFFERING FROM STROKE.CARASSO RL; VARDI J; RABAY JM et al.1977; J. NEUROL. NEUROSURG. PSYCHIATRY; G.B.; DA. 1977; VOL. 40; NO 10; PP. 967-969; BIBL. 18 REF.Article

Electric energy generation: economics, reliability and rates. Production d'énergie électrique: économie, fiabilité et tarifsVARDI, J; AVI-ITZHAK, B.1981, 176 p., isbn 0-262-22024-5Book

L'EFFETTO DELLA BROMOCRIPTINA SULLA SECREZIONE DELL' ENZIME DOPAMINA-B-IDROSSILASI (DBH) NEI MALATI DI PARKINSON = L'EFFET DE LA BROMOCRYPTINE SUR LA SECRETION DE LA DOPAMINE BETA HYDROXYLASE (DBH) DANS LA MALADIE DE PARKINSONVARDI J; FLECHTER S; OBERMAN Z et al.1979; RIV. NEUROL.; ITA; DA. 1979; VOL. 49; NO 4; PP. 291-296; ABS. FRE/ENG/GER; BIBL. 21 REF.Article

EEG SLEEP STUDY IN PARKINSONIAN PATIENTS UNDER BROMOCRYPTINE TREATMENTRABEY J; VARDI J; GLAUBMAN H et al.1978; EUROP. NEUROL.; CHE; DA. 1978; VOL. 17; NO 6; PP. 345-350; BIBL. 2 P.Article

PLASMA LEVELS OF 2-BR-ALPHA -ERGOCRIPTINE AFTER ACUTE AND CHRONIC ADMINISTRATION IN PARKINSONIAN PATIENTS. A RADIOIMMUNOASSAY STUDYFLECHTER S; VARDI J; OBERMAN Z et al.1979; CURR. THERAPEUT. RES.; USA; DA. 1979; VOL. 25; NO 4; PP. 540-543; BIBL. 22 REF.Article